PDR Pharma Corporation to Build New Plant for PET Radiopharmaceuticals and Other Products in Kazusa Academia Park | Nikkan Yakugyo – Comprehensive Pharmaceutical Industry Information Site

PeptiDream and its subsidiary PDR Pharma have disclosed plans to build a new plant in Chiba Prefecture's Kazusa Akademia Park for the manufacture and process development of PET products and radioisotope therapeutics and diagnostic agents.

Read in fullFrom the source, not the headline

sources corroborateOutlets reporting the same event

companies linkedAcross 0 themes, second pass

The story

PeptiDream and its subsidiary PDR Pharma announced on the 27th their plans to build a new plant in Chiba Prefecture's Kazusa Akademia Park. The plant will primarily manufacture PET products and will also conduct the manufacture and process development of radioisotope therapeutics and diagnostic agents.

The new plant is expected to strengthen the PET product manufacturing system and advance research and development of radioisotope-related therapeutics and diagnostic agents. The article does not provide details such as the specific facility scale, investment amount or completion date.

At a glance

EventPeptiDream and PDR Pharma announced plans to build a new plant

LocationThe plant is planned for construction in Chiba Prefecture's Kazusa Akademia Park

TargetIncludes the manufacture of PET products and the manufacture and research of radioisotope therapeutics and diagnostic agents

Reference information. Every claim resolves to something the story actually named.

Where this came from

We read each source in full and checked they agree on the core claim.

1/ 1 agree

All of them report the same thing.

nk.jiho.jpNews

PrimaryOpen

Read the original articleGo to the source page

Reference information generated from public sources. It does not solicit or advise on investments. Prices are 15-minute delayed.